Story thread · 2 reports / 2 sources

Oral nanomedicine improves cancer immunotherapy by harnessing gut bacterial metabolite

phys.org · 5hShare

A joint research team—led by professor Young Seok Cho from the School of Medicine, alongside professor James J. Moon from the University of Michigan—has developed the world's first oral, microbiome-based nanomedicine. By leveraging natural metabolites produced by gut bacteria, the new drug significantly enhances immune cells' ability to attack cancer cells. The study was published in Nature Nanotechnology.

First report: Korean, US researchers develop oral nanomedicine for cancer treatment — koreaherald.com, 1d